Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cancer02:18

Cancer

48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triggering tumorigenic signaling: Succinate dehydrogenase inhibitor (SDHi) fungicides induce oncometabolite accumulation and metabolic shift in human colon cells.

Environment international·2025
Same author

Downregulation of mitochondrial complex I induces ROS production in colorectal cancer subtypes that differently controls migration.

Journal of translational medicine·2023
Same author

[How dietary interventions can change lipid metabolism to affect tumor growth].

Medecine sciences : M/S·2022
Same author

Mitochondrial Fatty Acid β-Oxidation and Resveratrol Effect in Fibroblasts from Patients with Autism Spectrum Disorder.

Journal of personalized medicine·2021
Same author

Cellular prion protein dysfunction in a prototypical inherited metabolic myopathy.

Cellular and molecular life sciences : CMLS·2020
Same author

Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis.

The Journal of clinical investigation·2020

Related Experiment Video

Updated: Jun 28, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.2K

[Cancer-associated cachexia: an unresolved disease].

Jean Bastin1

  • 1Centre de recherche des Cordeliers, Inserm U1138, Sorbonne Université, Université Paris-Cité, Paris, France.

Medecine Sciences : M/S
|April 23, 2024
PubMed
Summary
This summary is machine-generated.

Cachexia, a cancer-related wasting syndrome, causes significant mortality. This condition involves muscle loss, fatigue, and inflammation, with poorly understood mechanisms and no current treatments.

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.6K
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

439

Related Experiment Videos

Last Updated: Jun 28, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.2K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.6K
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

439

Area of Science:

  • Oncology
  • Metabolic Disorders
  • Pathophysiology

Background:

  • Cachexia is a severe complication in advanced cancers, leading to significant morbidity and mortality.
  • It is characterized by involuntary weight loss, muscle wasting, and loss of adipose tissue, potentially resulting in death.
  • Current treatments for cachexia are lacking.

Purpose of the Study:

  • To elucidate the complex mechanisms underlying cancer cachexia.
  • To identify key mediators involved in its induction and progression.
  • To understand the multisystemic impairments associated with this condition.

Main Methods:

  • Review of existing literature on cancer cachexia.
  • Analysis of inflammatory, metabolic, and neuroendocrine pathways.
  • Investigation of tumor-host interactions and inter-organ crosstalk.

Main Results:

  • Cachexia involves a complex interplay of symptoms including fatigue, inflammation, pain, anorexia, and depression.
  • Multisystemic impairments affect organs such as muscle, adipose tissue, brain, immune system, and the gastrointestinal tract.
  • The disease mechanisms are driven by inflammatory, metabolic, and neuroendocrine factors.

Conclusions:

  • Cancer cachexia is a multifactorial condition with poorly understood mechanisms.
  • Further research into its drivers is crucial for developing effective treatments.
  • Understanding inter-organ crosstalk and mediator roles is key to combating this wasting syndrome.